Freddie Henriksson

681 total citations
15 papers, 528 citations indexed

About

Freddie Henriksson is a scholar working on Economics and Econometrics, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Freddie Henriksson has authored 15 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 4 papers in Pathology and Forensic Medicine and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Freddie Henriksson's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Multiple Sclerosis Research Studies (4 papers) and Pharmaceutical Economics and Policy (4 papers). Freddie Henriksson is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Multiple Sclerosis Research Studies (4 papers) and Pharmaceutical Economics and Policy (4 papers). Freddie Henriksson collaborates with scholars based in Sweden and Switzerland. Freddie Henriksson's co-authors include Bengt Jönsson, S. Fredrikson, Thomas Masterman, Bengt J nsson, Bo Jönsson, Jan Bolinder, C.–D. Agardh, Christian Berne, Per Stenström and Claes‐Göran Östenson and has published in prestigious journals such as Journal of Internal Medicine, European Journal of Neurology and Value in Health.

In The Last Decade

Freddie Henriksson

13 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Freddie Henriksson Sweden 8 229 208 139 74 68 15 528
Joel Bobula United States 12 139 0.6× 104 0.5× 247 1.8× 22 0.3× 97 1.4× 23 549
Amie T. Joyce United States 15 139 0.6× 56 0.3× 82 0.6× 39 0.5× 27 0.4× 17 512
Anouska Carter United Kingdom 12 26 0.1× 149 0.7× 48 0.3× 32 0.4× 77 1.1× 18 498
S T Thio Singapore 7 63 0.3× 58 0.3× 20 0.1× 44 0.6× 49 0.7× 10 418
Pranav Gandhi United States 13 54 0.2× 99 0.5× 47 0.3× 23 0.3× 51 0.8× 56 515
Priscilla Auguste United States 11 60 0.3× 42 0.2× 15 0.1× 55 0.7× 88 1.3× 17 563
T. Tamayo Germany 9 46 0.2× 25 0.1× 247 1.8× 164 2.2× 128 1.9× 14 591
Tzu‐Yun McDowell United States 6 64 0.3× 78 0.4× 23 0.2× 24 0.3× 22 0.3× 8 360
Marie Dalichampt France 11 27 0.1× 63 0.3× 15 0.1× 74 1.0× 28 0.4× 23 371
Makoto Tamura Japan 4 250 1.1× 26 0.1× 10 0.1× 37 0.5× 125 1.8× 6 479

Countries citing papers authored by Freddie Henriksson

Since Specialization
Citations

This map shows the geographic impact of Freddie Henriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Freddie Henriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Freddie Henriksson more than expected).

Fields of papers citing papers by Freddie Henriksson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Freddie Henriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Freddie Henriksson. The network helps show where Freddie Henriksson may publish in the future.

Co-authorship network of co-authors of Freddie Henriksson

This figure shows the co-authorship network connecting the top 25 collaborators of Freddie Henriksson. A scholar is included among the top collaborators of Freddie Henriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Freddie Henriksson. Freddie Henriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Costa‐Scharplatz, Madlaina, Magnus Tambour, Freddie Henriksson, & Björn Ställberg. (2013). Cost-Effectiveness of Glycopyrronium Compared to Tiotropium in COPD Patients from a Swedish Societal Perspective. Value in Health. 16(7). A371–A372.
2.
Bergvall, Niklas, Magnus Tambour, Freddie Henriksson, & S. Fredrikson. (2012). Cost-minimization analysis of fingolimod compared with natalizumab for the treatment of relapsing–remitting multiple sclerosis in Sweden. Journal of Medical Economics. 16(3). 349–357. 6 indexed citations
3.
Perseius, Kent‐Inge, Mats Samuelsson, Ewa Andersson, et al.. (2004). Does Dialectical Behavioural Therapy Reduce Treatment Costs for Patients with Borderline Personality Disorder. A Pilot Study. Nordic journal of nursing research. 24(2). 27–30. 2 indexed citations
4.
Henriksson, Freddie. (2002). Applications of Economic Models in Healthcare. PharmacoEconomics. 20(Supplement 1). 43–53. 22 indexed citations
5.
6.
Henriksson, Freddie, S. Fredrikson, Thomas Masterman, & Bengt Jönsson. (2001). Costs, quality of life and disease severity in multiple sclerosis: a cross‐sectional study in Sweden. European Journal of Neurology. 8(1). 27–35. 154 indexed citations
7.
8.
Kobelt, Gisela, Linus Jönsson, Freddie Henriksson, S. Fredrikson, & Bengt Jönsson. (2000). COST-UTILITY ANALYSIS OF INTERFERON BETA-1B IN SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS. International Journal of Technology Assessment in Health Care. 16(3). 768–780. 38 indexed citations
9.
Henriksson, Freddie, C.–D. Agardh, Christian Berne, et al.. (2000). Direct medical costs for patients with type 2 diabetes in Sweden. Journal of Internal Medicine. 248(5). 387–396. 117 indexed citations
10.
Henriksson, Freddie, Catharina Hjortsberg, & Clas Rehnberg. (1999). Pharmaceutical expenditure in Sweden. Health Policy. 47(2). 125–144. 13 indexed citations
11.
Henriksson, Freddie, C.–D. Agardh, Christian Berne, Jan Bolinder, & Bo Jönsson. (1999). [Health economics analysis of diabetes is necessary. It facilitates decision-making and international comparison].. PubMed. 96(37). 3915–6, 3919. 5 indexed citations
12.
Henriksson, Freddie & Bengt Jönsson. (1998). Diabetes: the cost of illness in Sweden. Journal of Internal Medicine. 244(6). 461–468. 69 indexed citations
13.
Henriksson, Freddie & Bengt J nsson. (1998). The Economic Cost of Multiple Sclerosis in Sweden in 1994. PharmacoEconomics. 13(5). 597–606. 62 indexed citations
14.
Gerdtham, Ulf‐G., et al.. (1998). The Effect of Changes in Treatment Patterns on Drug Expenditure. PharmacoEconomics. 13(1). 127–134. 29 indexed citations
15.
Gerdtham, Ulf‐G., et al.. (1998). Price Indices of Drugs and the Switching to New Drugs. PharmacoEconomics. 13(1). 71–80. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joel Bobula Breakdown of academic impact, for papers by Amie T. Joyce Breakdown of academic impact, for papers by Anouska Carter Breakdown of academic impact, for papers by S T Thio Breakdown of academic impact, for papers by Pranav Gandhi Breakdown of academic impact, for papers by Priscilla Auguste Breakdown of academic impact, for papers by T. Tamayo Breakdown of academic impact, for papers by Tzu‐Yun McDowell Breakdown of academic impact, for papers by Marie Dalichampt Breakdown of academic impact, for papers by Makoto Tamura
Rankless by CCL
2026